TABLE 2.
Clinical characteristics analysis for their prediction ability of potential severe patient
| Variable | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|
| OR (95% CI) | p‐Value | OR (95% CI) | p‐Value | |
| Sex | 4.195 (1.326–13.268) | 0.015* | 19.982 (1.142–349.538) | 0.0403* |
| Hypertension | 19.8 (2.324–168.66) | 0.006* | 25.219 (0.55–1156.349) | 0.098’ |
| Diabetes | 54147942.979 (0.0, Inf) | 0.993 | ||
| CVD | 179898122.163 (0.0, Inf) | 0.993 | ||
| COPD | 54147942.978 (0.0, Inf) | 0.993 | ||
| Cancer | 19053830.527 (0.0, Inf) | 0.990 | ||
| Cough | 0.833 (0.281, 2.474) | 0.743 | ||
| Myalgia | 1.600 (0.542, 4.726) | 0.395 | ||
| Headche | 1.083 (0.141, 8.307) | 0.939 | ||
| Emesis | 3.900 (0.710, 21.417) | 0.117 | ||
| Dyspnea | 8.100 (0.902, 72.708) | 0.062 | ||
| Age | 1.115 (1.055, 1.179) | <0.001* | 1.08 (1.003–1.162) | 0.041* |
| Temperature | 0.971 (0.560, 1.683) | 0.916 | ||
| Respiratory_rate | 1.045 (0.918, 1.191) | 0.503 | ||
| WBC | 1.72(1.212‐2.441) | 0.002* | 1.881(1.083‐3.267) | 0.025* |
| Lymphocyte | 0.881 (0.461, 1.686) | 0.703 | ||
Notes: Respiratory rate represented the initial respiratory rate on admission or on the day when visiting doctor. Influence factors that were statistically significant in the univariate logistic analysis were then included in the multivariate analysis. p‐Value showed the significance of group difference between severe and non‐severe.
Abbreviations: COPD, chronic obstructive pulmonary disease; CVD, cardiovascular diseases; bpm, breaths per min; OR, odd rate; WBC, white blood cells.